Pharma and biostatistics ·
ATOMIC: hazard ratio and absolute benefit at three years
The FDA approval of atezolizumab illustrates the distinction between HR, probabilities and absolute benefit. Practise with our Kaplan–Meier guide.
Algoria · Knowledge and updates
News and guides
Updates from Algoria, bioinformatics and pharma, alongside practical biostatistics guides and Methods Lab resources.
Company · Bioinformatics · Pharma · Biostatistics
Recent news
Practical guide ·
Kaplan–Meier, step by step
Explore censoring and numbers at risk, reproduce the same analysis in R and solve a fictional clinical case.
Algoria ·
Methods Lab: four tools to explore data and statistical methods
Effect Translator, Data Check, Survival Lab and Trial Lab are now available in Spanish and English. Explore effects, review a CSV locally and work through survival and trial simulations, with assumptions and limitations alongside each tool.
Guides and resources
Learn step by step with our guides and explore the interactive Methods Lab resources, with examples, assumptions and limitations.
Practical guide ·
Kaplan–Meier, step by step
Explore censoring and numbers at risk, reproduce the same analysis in R and solve a fictional clinical case.
Interactive resource
Effect Translator
Explore risks and absolute effects under the stated assumptions.
Interactive resource
Data Check
Review types, missing values and quality rules for a CSV in your browser.
Interactive resource
Survival Lab
Explore Kaplan–Meier, censoring and numbers at risk using synthetic data.
Interactive resource
Trial Lab
Compare trial scenarios with two groups and a simulated binary outcome.